Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Holly Maples

Concepts (98)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vancomycin
8
2023
85
2.320
Why?
Anti-Bacterial Agents
14
2025
807
1.630
Why?
Methicillin-Resistant Staphylococcus aureus
7
2023
82
1.490
Why?
Staphylococcal Infections
7
2023
285
1.110
Why?
Area Under Curve
5
2021
180
0.390
Why?
Microbial Sensitivity Tests
4
2021
284
0.360
Why?
Cystic Fibrosis
2
2022
154
0.300
Why?
Pediatrics
2
2013
293
0.290
Why?
Triazoles
2
2005
115
0.260
Why?
Malaria
1
2006
42
0.250
Why?
Pyrimidines
2
2005
199
0.250
Why?
Drug Monitoring
3
2020
83
0.230
Why?
Antifungal Agents
2
2005
347
0.230
Why?
Referral and Consultation
1
2006
292
0.220
Why?
Trichosporon
1
2003
13
0.220
Why?
Child
11
2024
7248
0.220
Why?
Patient-Centered Care
1
2025
141
0.220
Why?
Arthritis, Infectious
1
2024
43
0.210
Why?
Famotidine
1
2003
11
0.210
Why?
Humans
21
2025
52483
0.200
Why?
Histamine H2 Antagonists
1
2003
26
0.200
Why?
Medicaid
1
2025
264
0.200
Why?
Mycoses
1
2003
152
0.200
Why?
Osteomyelitis
1
2024
125
0.190
Why?
Bacteremia
1
2023
92
0.190
Why?
Practice Guidelines as Topic
3
2020
488
0.190
Why?
Kidney Failure, Chronic
1
2003
210
0.170
Why?
Consensus
1
2021
181
0.170
Why?
Communicable Diseases
1
2020
55
0.160
Why?
United States
7
2025
5192
0.140
Why?
Hospitals, Pediatric
1
2018
243
0.140
Why?
Respiratory System
1
2015
28
0.120
Why?
Tracheostomy
1
2015
76
0.120
Why?
Respiratory Tract Infections
1
2015
87
0.110
Why?
Inappropriate Prescribing
1
2013
23
0.100
Why?
Drug Resistance, Bacterial
1
2013
82
0.100
Why?
Infant
5
2015
3733
0.090
Why?
Pharmacists
2
2020
144
0.080
Why?
Plasmodium
1
2006
5
0.070
Why?
Specialization
1
2006
49
0.060
Why?
Geography
1
2006
65
0.060
Why?
Antimalarials
1
2006
32
0.060
Why?
Medicine
1
2006
54
0.060
Why?
Child, Preschool
4
2015
4076
0.060
Why?
Amphotericin B
1
2005
103
0.060
Why?
Azithromycin
1
2005
26
0.060
Why?
Antiretroviral Therapy, Highly Active
1
2004
32
0.060
Why?
Candidiasis
1
2005
113
0.060
Why?
Treatment Refusal
1
2004
35
0.060
Why?
HIV-1
1
2004
59
0.060
Why?
Mucorales
1
2024
12
0.060
Why?
Mucormycosis
1
2024
28
0.050
Why?
Micronesia
1
2024
112
0.050
Why?
Fatal Outcome
1
2003
197
0.050
Why?
Neutropenia
1
2003
115
0.050
Why?
Tissue Distribution
1
2003
171
0.050
Why?
Methicillin
1
2020
11
0.040
Why?
Adolescent
3
2015
6739
0.040
Why?
Societies, Pharmaceutical
1
2020
14
0.040
Why?
HIV Infections
1
2004
389
0.040
Why?
Staphylococcus aureus
1
2023
338
0.040
Why?
Aging
1
2005
701
0.040
Why?
Arkansas
1
2025
2028
0.040
Why?
Societies, Medical
1
2020
200
0.040
Why?
Adult
1
2015
14161
0.040
Why?
Medical Staff, Hospital
1
2018
17
0.040
Why?
Lung
1
2022
509
0.040
Why?
Bacteriological Techniques
1
2018
42
0.040
Why?
Developed Countries
1
2018
17
0.040
Why?
Inflammation
1
2022
641
0.040
Why?
Bacterial Infections
1
2018
101
0.030
Why?
Acute Kidney Injury
1
2020
319
0.030
Why?
Pseudomonas Infections
1
2015
54
0.030
Why?
Pseudomonas aeruginosa
1
2015
78
0.030
Why?
Infusions, Intravenous
2
2005
220
0.030
Why?
Infant, Newborn
2
2015
2867
0.030
Why?
Government Regulation
1
2013
15
0.030
Why?
Infection Control
1
2013
47
0.030
Why?
Patient Safety
1
2013
104
0.020
Why?
Program Development
1
2013
165
0.020
Why?
Male
3
2024
26761
0.020
Why?
Health Policy
1
2013
158
0.020
Why?
Program Evaluation
1
2013
353
0.020
Why?
Female
3
2024
28171
0.020
Why?
Animals
1
2006
13505
0.020
Why?
Attitude of Health Personnel
1
2013
360
0.020
Why?
Retrospective Studies
2
2015
6607
0.020
Why?
Directly Observed Therapy
1
2004
7
0.010
Why?
Drug Resistance, Viral
1
2004
8
0.010
Why?
Foster Home Care
1
2004
13
0.010
Why?
Treatment Failure
1
2004
122
0.010
Why?
Viral Load
1
2004
82
0.010
Why?
RNA, Viral
1
2004
127
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
339
0.010
Why?
Home Care Services
1
2004
72
0.010
Why?
Mass Spectrometry
1
2005
292
0.010
Why?
Child Abuse
1
2004
140
0.010
Why?
Infant, Premature
1
2005
333
0.010
Why?
Maples's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description